Skip to content

Checked

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

NCT06215716 on ClinicalTrials.gov

Study listings come from ClinicalTrials.gov, where sponsors register and update their own studies. A listing does not mean a study is safe or effective, and DatenUS does not recommend any study. Talk with your doctor before joining a clinical trial, and use ClinicalTrials.gov for contact details and full eligibility rules.

Status
Recruiting
Phase
Phase 3
Interventional
Planned enrollment
1,650
Participants, all sites
U.S. sites
203
In 34 states

Study details

Conditions
NASH With Fibrosis, MASH With Fibrosis
Sponsor
Akero Therapeutics, Inc (Industry)
Ages
18 to 80 years
Sex
All
Healthy volunteers
Not accepted
Start
12/01/2023
Primary completion (expected)
February 2033
Last updated by sponsor
10/15/2026

Full eligibility rules, contacts and site names: NCT06215716 on ClinicalTrials.gov

Where the study has sites

Cities with at least one listed U.S. site. Some sites may not be enrolling yet.

  • Alabama: Birmingham, Dothan
  • Arizona: Tucson (4), Chandler, Flagstaff, Peoria
  • Arkansas: Conway, Jonesboro, Little Rock, North Little Rock
  • California: Los Angeles (3), San Diego (3), Lancaster (2), San Francisco (2), Chula Vista, Coronado, Escondido, Folsom, Inglewood, La Mesa, Long Beach, Newport Beach and 6 more
  • Colorado: Aurora, Colorado Springs, Englewood
  • Connecticut: New Haven
  • District of Columbia: Washington D.C. (2)
  • Florida: Miami (2), Winter Park (2), Bradenton, Brandon, Doral, Fort Myers, Gainesville, Hialeah Gardens, Inverness, Jacksonville, Lady Lake, Lakewood Rch and 20 more
  • Georgia: Atlanta, Columbus, Gainesville, Marietta
  • Illinois: Chicago
  • Indiana: Hammond, Indianapolis, South Bend
  • Iowa: West Des Moines
  • Kansas: Topeka, Wichita
  • Kentucky: Louisville
  • Louisiana: New Orleans (2), Bastrop, Covington, Houma, Marrero, Metairie, Shreveport, West Monroe
  • Maryland: Baltimore, Glen Burnie, Greenbelt
  • Massachusetts: New Bedford
  • Michigan: Novi, Southfield, Wyoming, Ypsilanti
  • Mississippi: Flowood
  • Missouri: Columbia, Kansas City, St Louis
  • Nevada: Las Vegas (2), Reno
  • New Jersey: Florham Park, Jackson, Ridgewood, Somers Point, Sparta
  • New Mexico: Santa Fe
  • New York: New York (4), Buffalo, Manhasset, Rochester
  • North Carolina: Chapel Hill, Charlotte, Durham, Fayetteville, Morehead City, New Bern, Raleigh, Statesville
  • Ohio: Columbus, Dayton, Springboro, Westlake
  • Pennsylvania: Philadelphia (2), Hershey, Pittsburgh
  • South Carolina: Charleston, Columbia, Summerville
  • Tennessee: Chattanooga, Clarksville, Hermitage, Nashville
  • Texas: San Antonio (7), Houston (6), Dallas (5), Austin (3), McAllen (2), Waco (2), Amarillo, Bellaire, Brownsville, Corpus Christi, Denison, Edinburg and 7 more
  • Utah: Ogden, Salt Lake City, Sandy City, South Ogden
  • Virginia: Richmond (4), Falls Church, Newport News, Norfolk, Roanoke, Suffolk
  • Washington: Seattle, Spokane
  • Wisconsin: Madison

Frequently asked questions

What does recruiting mean?
Recruiting means the study is currently enrolling participants. Not yet recruiting means it has been registered but has not started enrolling. Enrolling by invitation means participants are selected by the study team rather than through open enrollment.
How do I join a clinical trial?
Read the full eligibility criteria and contact information on ClinicalTrials.gov, then talk with your doctor about whether a study may be right for you. The study team decides who can enroll.

Source: ClinicalTrials.gov, National Library of Medicine · Last updated 10/15/2026